AAAAAA
Results:
1-7
|
Results: 7
Authors:
Schmitz, M
Michl, GM
Walli, R
Bogner, J
Bedynek, A
Seidel, D
Goebel, FD
Demant, T
Citation: M. Schmitz et al., Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy, J ACQ IMM D, 26(3), 2001, pp. 225-235
Authors:
Walli, R
Michl, GM
Bogner, JR
Goebel, FD
Citation: R. Walli et al., Improvement of HAART-associated insulin resistance and dyslipidemia after replacement of protease inhibitors with abacavir, EUR J MED R, 6(10), 2001, pp. 413-421
Authors:
Bogner, JR
Walli, R
Goebel, FD
Citation: Jr. Bogner et al., Th1/Th2 shift in HIV lymph nodes: No contribution of CD60 cells, INFECTION, 29(1), 2001, pp. 32-36
Authors:
Goebel, FD
Walli, R
Citation: Fd. Goebel et R. Walli, Metabolic complications of antiretroviral treatment of HIV infection, DEUT MED WO, 125(24), 2000, pp. 771-773
Authors:
Walli, R
Michl, GM
Muhlbayer, D
Brinkmann, L
Goebel, FD
Citation: R. Walli et al., Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus, RES EXP MED, 199(5), 2000, pp. 253-262
Authors:
Bornhovd, E
Sakrauski, AK
Bruhl, H
Walli, R
Plewig, G
Rocken, M
Citation: E. Bornhovd et al., Multiple circumscribed subcutaneous lipomas associated with use of human immunodeficiency virus protease inhibitors?, BR J DERM, 143(5), 2000, pp. 1113-1114
Authors:
Segerer, S
Bogner, JR
Walli, R
Loch, O
Goebel, FD
Citation: S. Segerer et al., Hyperlipidemia under treatment with proteinase inhibitors, INFECTION, 27(2), 1999, pp. 77-81
Risultati:
1-7
|